Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
NurExone Forms Exo-Top in the U.S. for Exosome Manufacture & Commercialization (click to learn more)
DiagnosTear Advances Production for First 100,000 TeaRx(TM) Red Eye Diagnostic Devices (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Puma Biotechnology Inc
PBYI
Healthcare
Biotechnology
Puma Biotechnology, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of products to enhance cancer care. The Company's lead product is NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Neratinib is a potent irreversible tyrosine kinase inhibitor (TKI) that blocks signal transduction through the epidermal...
growth factor receptors, HER1, HER2 and HER4 It also engaged in the development and commercialization of, alisertib. Alisertib is a selective, small molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A. Its neratinib has clinical application in the treatment of several other cancers as well, including other tumor types that over-express or have a mutation in HER2 or epidermal growth factor receptor (EGFR), such as breast cancer, cervical cancer, lung cancer, or other solid tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PBYI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(10)
•••
MikeTester
X
Post by
MikeTester
on Jan 24, 2025 5:59am
Puma Biotechnology (NASDAQ: PBYI): Navigating Cancer Therape
Looks like PBYI is making some serious moves in the cancer therapeutics space. Q3 numbers are looking solid with 43.5% revenue growth to $80.54M. NERLYNX continues to be their bread and butter
...more
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 08, 2021 9:55am
PBYI ....is that a "drumroll" I'm hearing ???
Now $4.21....and heading North....break $4.25 and it just might catch. Cheers !
QMET and QIMC Announce Strategic Work Program for the Matane Natural Hydrogen Project
posted Feb 06, 2025 9:00am by
Q Precious & Battery Metals Corp.
-
|
This partnership between QMET and QIMC reflects a shared commitment to positioning Québec as a leader in clean natural hydrogen exploration—a clean and renewable energy resource. The project aligns with a sustainable development strategy, leveraging Québec’s unique geological advantages while ensuring a minimal environmental footprint. ...read more
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 3:03pm
PBYI ...... Thru DTL ....on watch
Start the drumroll Cheers !
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 2:33pm
PBYI ....opportunity is a knockin....getting my B oda ready
just sayin......cheap paper makes the world go around !!!
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 2:13pm
PBYI ....needs a break of $4.23 on this swing
Never know.... Cheers 1
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 1:16pm
PBYI ...... Come on down.....
You're the next contestant on the Price is Right... LoL Beats Vegas by a mile !!!
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 1:01pm
PBYI ..... dang....I was posting on AMPG's board
I was a buyer sub $4 and just above...scalped it for about 20 cents a share Hold some and waiting for a possible "Gap Fill"....Cheers !
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 12:18pm
PBYI .... Take a look at another "catastrophy"......
And tell me what you think. DCPH....down 75% on over 20 million shares re: top - line results sucked PBYI was an ER report Sheesh
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 12:06pm
PBYI .....for this sell off catastrophy....
It sure is low volume .....2.5 million shares and it's down over 35% This could get a nice bounce....maybe
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 12:02pm
PBYI ....here come the FOMO's now
JMHO Small add here
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 11:55am
PBYI ..... 16 cents shy of sub $4
Just keeping u up to date .... LoL
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 11:40am
PBYI ..... The "Street defeat" always goes lower than ....
you invisioned....just like what we are seeing here Markets correct by going in the opposite direction...falling sharply after sustained broad rallies. The world ebbs & flows PBYI ....now at $4
...more
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 10:59am
PBYI .....sub $4.00 in the cards??
Wait for it....... Looks like I'm not the only one that wants "Cheap Paper" The Directors are getting "hungry" again LMFAO
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 10:43am
PBYI ....come on Mr. Maggot....drop this sucker!!!
I can use some "cheap paper" Cheers !
(70)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 05, 2021 10:26am
PBYI ..... New All-time low established..... $4.48
Spear-catching now ..... anyone ?
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Results Beyond Expectation for First Completed Drill Hole; up to 8 g/t Gold in Getchell Trend
New Study Demonstrates the Economic Value of Baptiste Nickel Project for More Than 30 Years
Coniagas Progresses Drill Program on Near Surface and Extensive Ni-Cu-Co-PGM Mineralization Zones
Why 2025 is set to be a Game Changer for this Critical Raw Materials Stock